CONDENSED STATEMENTS OF CASH FLOWS - USD ($) | 3 Months Ended |
Jun. 30, 2023 | Jun. 30, 2022 |
Cash flows from operating activities: | | |
Net income (loss) | $ 959,983 | $ 3,243,726 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | (1,017,868) | (3,230,668) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 2,691 | (450) |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 1 |
(Decrease) Increase in accounts payable affiliates | (999,662) | (1,447,179) |
Net cash (used in) provided by operating activities | (1,054,856) | (1,434,570) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 1,017,083 | 3,230,668 |
Net cash provided by investing activities | 1,017,083 | 3,230,668 |
Cash flows from financing activities: | | |
Distributions | 0 | (2,957,455) |
Net cash used in financing activities | 0 | (2,957,455) |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (37,773) | (1,161,357) |
Cash and cash equivalents, beginning | 508,245 | 2,370,898 |
Cash and cash equivalents, ending | 470,472 | 1,209,541 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 2,706,879 | 0 |
Series 20 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 21 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 22 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 23 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 24 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 25 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 26 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 27 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 28 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 29 | | |
Cash flows from operating activities: | | |
Net income (loss) | 357,480 | (16,039) |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | (430,628) | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 2,582 | (56) |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | (406,423) | 1,128 |
Net cash (used in) provided by operating activities | (476,989) | (14,967) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 429,843 | 0 |
Net cash provided by investing activities | 429,843 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (47,146) | (14,967) |
Cash and cash equivalents, beginning | 47,146 | 108,768 |
Cash and cash equivalents, ending | 0 | 93,801 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 2,706,879 | 0 |
Series 30 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 31 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 32 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 33 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 34 | | |
Cash flows from operating activities: | | |
Net income (loss) | (11,396) | (16,330) |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 27 | (56) |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 4,623 | 4,623 |
Net cash (used in) provided by operating activities | (6,746) | (11,763) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (6,746) | (11,763) |
Cash and cash equivalents, beginning | 31,891 | 81,705 |
Cash and cash equivalents, ending | 25,145 | 69,942 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 35 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 36 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 37 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 38 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 39 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 40 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 41 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 42 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 43 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | 0 |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | 0 |
Net cash (used in) provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 0 |
Net cash provided by investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 0 |
Cash and cash equivalents, beginning | 0 | 0 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 44 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 1,755,220 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | (1,746,178) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | 0 |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | (28,269) |
Net cash (used in) provided by operating activities | 0 | (19,227) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 1,746,178 |
Net cash provided by investing activities | 0 | 1,746,178 |
Cash flows from financing activities: | | |
Distributions | 0 | (2,957,455) |
Net cash used in financing activities | 0 | (2,957,455) |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | (1,230,504) |
Cash and cash equivalents, beginning | 0 | 1,230,504 |
Cash and cash equivalents, ending | 0 | 0 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 45 | | |
Cash flows from operating activities: | | |
Net income (loss) | 0 | 1,450,949 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | 0 | (1,405,869) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 0 | (113) |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 0 |
(Decrease) Increase in accounts payable affiliates | 0 | (1,134,074) |
Net cash (used in) provided by operating activities | 0 | (1,089,107) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 0 | 1,405,869 |
Net cash provided by investing activities | 0 | 1,405,869 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 0 | 316,762 |
Cash and cash equivalents, beginning | 0 | 287,530 |
Cash and cash equivalents, ending | 0 | 604,292 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | 0 | 0 |
Series 46 | | |
Cash flows from operating activities: | | |
Net income (loss) | 613,899 | 69,926 |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | | |
Gain on disposition of Operating Partnerships | (587,240) | (78,621) |
Changes in assets and liabilities | | |
(Increase) Decrease in other assets | 82 | (225) |
(Decrease) Increase in accounts payable and accrued expenses | 0 | 1 |
(Decrease) Increase in accounts payable affiliates | (597,862) | (290,587) |
Net cash (used in) provided by operating activities | (571,121) | (299,506) |
Cash flows from investing activities: | | |
Proceeds from the disposition of Operating Partnerships | 587,240 | 78,621 |
Net cash provided by investing activities | 587,240 | 78,621 |
Cash flows from financing activities: | | |
Distributions | 0 | 0 |
Net cash used in financing activities | 0 | 0 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 16,119 | (220,885) |
Cash and cash equivalents, beginning | 429,208 | 662,391 |
Cash and cash equivalents, ending | 445,327 | 441,506 |
Supplemental schedule of noncash investing and financing activities | | |
The general partner's equity balance was increased and accounts payable affiliates was reduced as a result of forgiveness of debt with an affiliate of the general partner. | $ 0 | $ 0 |